98%
921
2 minutes
20
Background: Long-term health effects of adverse childhood experiences (ACEs) include cognitive decline that occurs later in life. Subjective cognitive decline (SCD), recognized as an early indicator of Alzheimer's disease, may present an essential period for intervention in populations with ACEs.
Objective: This review aims to explore the associations between ACEs and SCD, while examining the potential moderating effects of sociodemographic factors METHODS: A systematic search of four databases (Medline, PsycINFO, CINAHL, and Web of Science) was conducted from inception to July 2024. Eligible studies included adults with a history of ACEs and self-reported SCD. In total, twelve studies were included, primarily using U.S.-based samples, with sample sizes ranging from 46 to over 195,000 participants.
Results: The evidence of a dose-response relationship highlights the link between ACEs and SCD. The risk of SCD increases among adults over 65, lower-income groups, and sexual minorities. However, gender differences were inconsistently observed across studies. Mental health conditions, particularly depression is a significant risk factor.
Conclusions: Early screening and intervention for SCD among individuals with high ACE exposure may help delay the progression to severe cognitive impairment. However, the reliance on cross-sectional studies and high risk of bias limit causal inferences. Future research should explore longitudinal studies with diverse populations to clarify causal pathways and the role of sociodemographic factors in the ACE-SCD relationship.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.archger.2025.105773 | DOI Listing |
J Agric Food Chem
September 2025
Department of Food Science and Engineering, Ningbo University, Ningbo 315211, P.R. China.
Sleep deprivation (SD) is a major contributor to cognitive impairment, often accompanied by central neuroinflammation and gut microbiota dysbiosis. The tryptophan (TRP) pathway, activated via indoleamine 2,3-dioxygenase (IDO), serves as a critical link between immune activation and neuronal damage. Umbelliferone (UMB), a naturally occurring coumarin compound, possesses anti-inflammatory, antioxidant, and microbiota-modulating properties.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Background: Stroke is a leading cause of death and disability globally, with frequent cognitive sequelae affecting up to 60% of stroke survivors. Despite the high prevalence of post-stroke cognitive impairment (PSCI), early detection remains underemphasized in clinical practice, with limited focus on broader neuropsychological and affective symptoms. Stroke elevates dementia risk and may act as a trigger for progressive neurodegenerative diseases.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
The "biological view" of Alzheimer's disease (AD) focuses on the role of plaques and tangles and excludes syndromes from the disease definition. However, cognitive syndromes are fundamental aspects of AD and are the ultimate target of treatments. Accordingly, the study of cognitive syndromes should remain a major goal of AD research.
View Article and Find Full Text PDFAm J Audiol
September 2025
Department of Special Education and Communication Disorders, University of Nebraska-Lincoln.
Purpose: This study investigated the effects of age-related hearing decline on functional networks using resting-state functional magnetic resonance imaging (rs-fMRI). The main objective of the present study was to examine resting-state functional connectivity (RSFC) and graph theory-based network efficiency metrics in 49 adults categorized by age and hearing thresholds to identify the neural mechanisms of age-related hearing decline.
Method: Forty-nine adults with self-reported normal hearing underwent pure-tone audiometry and rs-fMRI.
CNS Drugs
September 2025
Global Health Neurology Lab, Sydney, NSW, 2150, Australia.
Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.
View Article and Find Full Text PDF